Dr. Reddy’s Labs board meets to review Q2 results
Bitget2026/09/22 18:19- Dr. Reddy’s will hold a board meeting on Oct. 23, 2026 to review unaudited Q2 results ended Sept. 30, 2026.
- Trading window for the company’s securities to stay closed from Sept. 24, 2026 through Oct. 25, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Subscription multiplier reaches 4 times! "AI Ring" Oura IPO receives enthusiastic response
Smart ring manufacturer Oura's IPO was oversubscribed by approximately four times, planning to issue 50 million shares at a maximum price of $44 per share, aiming to raise up to $2.2 billions, with a fully diluted valuation of about $15 billions. Against the backdrop of companies like Holtec Nuclear withdrawing their IPO plans due to market conditions, Oura is expected to become the first major IPO in nearly three months to raise over $1 billion, injecting new vitality into the long-dormant U.S. IPO market.